These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 26122548

  • 1. [(68) Ga]-HP-DO3A-nitroimidazole: a promising agent for PET detection of tumor hypoxia.
    Wu Y, Hao G, Ramezani S, Saha D, Zhao D, Sun X, Sherry AD.
    Contrast Media Mol Imaging; 2015; 10(6):465-72. PubMed ID: 26122548
    [Abstract] [Full Text] [Related]

  • 2. Synthesis of 68Ga-labeled DOTA-nitroimidazole derivatives and their feasibilities as hypoxia imaging PET tracers.
    Hoigebazar L, Jeong JM, Hong MK, Kim YJ, Lee JY, Shetty D, Lee YS, Lee DS, Chung JK, Lee MC.
    Bioorg Med Chem; 2011 Apr 01; 19(7):2176-81. PubMed ID: 21419635
    [Abstract] [Full Text] [Related]

  • 3. Nitroimidazole-Containing H2dedpa and H2CHXdedpa Derivatives as Potential PET Imaging Agents of Hypoxia with (68)Ga.
    Ramogida CF, Pan J, Ferreira CL, Patrick BO, Rebullar K, Yapp DT, Lin KS, Adam MJ, Orvig C.
    Inorg Chem; 2015 May 18; 54(10):4953-65. PubMed ID: 25928800
    [Abstract] [Full Text] [Related]

  • 4. 68Ga-labeled PET tracers for targeting tumor hypoxia: Role of bifunctional chelators on pharmacokinetics.
    Mittal S, Sharma R, Mallia MB, Sarma HD.
    Nucl Med Biol; 2021 May 18; 96-97():61-67. PubMed ID: 33838524
    [Abstract] [Full Text] [Related]

  • 5. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
    Fani M, Tamma ML, Nicolas GP, Lasri E, Medina C, Raynal I, Port M, Weber WA, Maecke HR.
    Mol Pharm; 2012 May 07; 9(5):1136-45. PubMed ID: 22497506
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of (68)Ga-labeled multivalent nitroimidazole derivatives for hypoxia imaging.
    Seelam SR, Lee JY, Lee YS, Hong MK, Kim YJ, Banka VK, Lee DS, Chung JK, Jeong JM.
    Bioorg Med Chem; 2015 Dec 15; 23(24):7743-50. PubMed ID: 26643217
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and evaluation of gallium-68-labeled nitroimidazole-based imaging probes for PET diagnosis of tumor hypoxia.
    Shimizu Y, Nakai Y, Iikuni S, Watanabe H, Nakamoto Y, Ono M.
    Ann Nucl Med; 2021 Mar 15; 35(3):360-369. PubMed ID: 33423155
    [Abstract] [Full Text] [Related]

  • 9. 68Ga-DOTA-NGR as a novel molecular probe for APN-positive tumor imaging using MicroPET.
    Zhang J, Lu X, Wan N, Hua Z, Wang Z, Huang H, Yang M, Wang F.
    Nucl Med Biol; 2014 Mar 15; 41(3):268-75. PubMed ID: 24438818
    [Abstract] [Full Text] [Related]

  • 10. Recent Advances of 68Ga-Labeled PET Radiotracers with Nitroimidazole in the Diagnosis of Hypoxia Tumors.
    Nguyen AT, Kim HK.
    Int J Mol Sci; 2023 Jun 23; 24(13):. PubMed ID: 37445730
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Design, Synthesis, and Biological Evaluation of 68Ga-DOTA-PA1 for Lung Cancer: A Novel PET Tracer for Multiple Somatostatin Receptor Imaging.
    Liu F, Liu T, Xu X, Guo X, Li N, Xiong C, Li C, Zhu H, Yang Z.
    Mol Pharm; 2018 Feb 05; 15(2):619-628. PubMed ID: 29278911
    [Abstract] [Full Text] [Related]

  • 13. Pre-clinical evaluation of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 for imaging of insulinoma.
    Selvaraju RK, Velikyan I, Asplund V, Johansson L, Wu Z, Todorov I, Shively J, Kandeel F, Eriksson B, Korsgren O, Eriksson O.
    Nucl Med Biol; 2014 Jul 05; 41(6):471-6. PubMed ID: 24857864
    [Abstract] [Full Text] [Related]

  • 14. Preclinical evaluation of 68 Ga-labeled peptide CK2 for PET imaging of NRP-1 expression in vivo.
    Liu Q, Cai S, Ye J, Xie Q, Liu R, Qiu L, Lin J.
    Eur J Nucl Med Mol Imaging; 2024 Jun 05; 51(7):1826-1840. PubMed ID: 38319321
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vivo evaluation of a radiogallium-labeled bifunctional radiopharmaceutical, Ga-DOTA-MN2, for hypoxic tumor imaging.
    Sano K, Okada M, Hisada H, Shimokawa K, Saji H, Maeda M, Mukai T.
    Biol Pharm Bull; 2013 Jun 05; 36(4):602-8. PubMed ID: 23546294
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and Bioevaluation of Novel [18F]FDG-Conjugated 2-Nitroimidazole Derivatives for Tumor Hypoxia Imaging.
    Yang X, Wang F, Zhu H, Yang Z, Chu T.
    Mol Pharm; 2019 May 06; 16(5):2118-2128. PubMed ID: 30964298
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 68Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapy.
    Bouziotis P, Stellas D, Thomas E, Truillet C, Tsoukalas C, Lux F, Tsotakos T, Xanthopoulos S, Paravatou-Petsotas M, Gaitanis A, Moulopoulos LA, Koutoulidis V, Anagnostopoulos CD, Tillement O.
    Nanomedicine (Lond); 2017 Jul 06; 12(13):1561-1574. PubMed ID: 28621567
    [Abstract] [Full Text] [Related]

  • 20. Novel "bi-modal" H2dedpa derivatives for radio- and fluorescence imaging.
    Ramogida CF, Murphy L, Cawthray JF, Ross JD, Adam MJ, Orvig C.
    J Inorg Biochem; 2016 Sep 06; 162():253-262. PubMed ID: 26652124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.